An Ottawa-based company is refilling its trough of funding as it develops an alternative to antibiotic-based livestock feed.
Avivagen said Friday it has raised $1.25 million in a private placement of shares and related warrants. The company issued 2.5 million units priced at 50 cents each on the TSX Venture Exchange, entitling buyers to one common share of the firm and a warrant for a half-share at $0.75 over a period of three years.
Avivagen said in a press release it intends to use the new funds in product development and general working purposes. The funding tops up a larger $5.26-milion round closed last March.
OBJ360 (Sponsored)
![Stonefields Estate barn](https://assets.obj.ca/2024/06/Stonefields-barn-20240624_115231_0000-300x169.jpg)
Stonefields Estate will make your next corporate event unforgettable
Stonefields Estate feels like the kind of place where time stands still. It may be the idyllic countryside location or the historic farm buildings dotting the property that give it
![Chef Yannick Anton of the Cordon Bleu](https://assets.obj.ca/2024/06/Chef-Yannick_20240625_104056_0000-300x169.jpg)
Bringing France to Ottawa: Chef Yannick Anton recognized for contributions to the capital food scene
At the age of 14 in Nice, France, Yannick Anton was asked to choose a path for his career. After a few cooking classes in school, and seeing his grandfather
The Ottawa life sciences company develops natural health products aimed at replacing the use of antibiotics in livestock feed. The firm has racked up more than $27 million in losses and has used funding rounds like these to sustain itself until it obtains the regulatory approvals it needs in jurisdictions around the world to start turning a profit.